Aether Industries Q4 PAT rises 13% YoY to Rs 26 cr

16 Jun 2022 , 03:53 PM

Profit before tax rose by 15.85% to Rs 35.16 crore in Q4 FY22 from Rs 30.35 crore in Q4 FY21. Total expenses surged 30.7% year on year (YoY) to Rs 112.54 crore in the quarter ended 31 March 2022. Cost of materials consumed jumped 64.22% YoY to Rs 83.92 crore during the period under review. Revenue from exports (including deemed exports and SEZ sales) increased by 52.71% in Q4 FY22 as compared with Q4 FY21. EBITDA increased 16.46% to Rs 42.32 crore in Q4 FY22 from Rs 36.34 crore in Q4 FY21. During the year, the specialty chemicals company reported 53.16% surge in net profit to Rs 108.93 crore on 31.56% jump in revenue from operations to Rs 597.02 crore in the financial year ended 31 March 2022 over the financial year ended 31 March 2021. The order book as of 31 March 2022 is Rs 247.05 crore, compared to Rs 212.81 crore as of 31 March 2021. Aman Desai, promoter & whole-time director of Aether Industries said, In our sales mix the Pharma sector continues to dominate with 59.54%, followed by the Agrochemicals sector which grew by 4.08% to 24.68%. Other segments like Coatings grew by 0.54% to 3.31% in addition to new segments like Material Science contributing 4.21% and Oil and Gas contributing 0.92% besides others. 64.67% of our revenues comes from exports (including SEZ sales and sales to EOU units in India), balance 35.33% catering to domestic sales. He added, If we were to speak of the three business models, the sales revenue break-up for the FY22 looks more interesting with Large Scale Manufacturing contributing 76.03% (FY21 it was72.23%), Contract Manufacturing contributing 23.77% (FY21 19.38%) and Contract Research and Manufacturing Services (CRAMS) contributing 8.12% (FY21 7.98%) of the revenue from operations. If we were to look at the geographic mix, India accounts for 58.77%, Europe accounts for 30.30%, USA accounts for 6.25%, Asia accounts for 4.27% and ROW accounts for 0.42% of the revenue from operations in FY22. The expenses towards R&D (revenue plus capital) have been increasing year on year in absolute terms and also as a percentage of total revenue, wherein in the FY22 6.60% our total revenue is spent towards R&D. Focus of the company has always been on the quality, environment, health & safety (QEHS), where we have a total of 15.44% of manpower (of our total strength as on March 31, 2022) deployed to these areas, he added. Aether Industries is a specialty chemical manufacturer in India focused on producing advanced intermediates and specialty chemicals involving complex and differentiated chemistry and technology core competencies. Shares of Aether Industries fell 1.95% at Rs 780.10 on the BSE. Powered by Capital Market – Live News